MedPath

Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

Clinical Trials

1.5k

Active:26
Completed:796

Trial Phases

5 Phases

Phase 1:32
Phase 2:124
Phase 3:35
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1117 trials with phase data)• Click on a phase to view related trials

Not Applicable
748 (67.0%)
Phase 4
178 (15.9%)
Phase 2
124 (11.1%)
Phase 3
35 (3.1%)
Phase 1
32 (2.9%)

A Study Comparing the Safety, Efficacy, and Diffusion of Letibotulinum Toxin A Versus Other Botulinum Toxin Products in Adults With Moderate-to-Severe Forehead Wrinkles

Not Applicable
Completed
Conditions
Forehead Rhytides
Interventions
Drug: Letibotulinum toxin A
Drug: Prabotulinum toxin A
Drug: Onabotulinum toxin A
First Posted Date
2025-07-18
Last Posted Date
2025-07-18
Lead Sponsor
Yonsei University
Target Recruit Count
20
Registration Number
NCT07072806
Locations
🇰🇷

Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

An Exploratory Preliminary Study on the Effect of Combined Transcranial Photobiomodulation(tPBM)-Transauricular Vagus Nerve Stimulation(taVNS) on Alcohol Craving and Neurophysiological Marker in Drinkers (in South Korea)

Not Applicable
Conditions
Normal Subjects
First Posted Date
2025-07-17
Last Posted Date
2025-07-17
Lead Sponsor
Yonsei University
Target Recruit Count
60
Registration Number
NCT07071493
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Thickness Map-Guided vs. Empirical PV Isolation Using Pulsed Field Ablation for Paroxysmal AF

Not Applicable
Not yet recruiting
Conditions
Atrial Fibrillation
First Posted Date
2025-07-16
Last Posted Date
2025-07-16
Lead Sponsor
Yonsei University
Target Recruit Count
298
Registration Number
NCT07068646
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice

Not yet recruiting
Conditions
Heart Valve Diseases
Aortic Valve Stenosis
Aortic Valve Insufficiency
Mitral Valve Insufficiency
Mitral Valve Prolapse
Tricuspid Valve Insufficiency
Rheumatic Heart Disease
Aortic Diseases
First Posted Date
2025-07-16
Last Posted Date
2025-07-16
Lead Sponsor
Yonsei University
Target Recruit Count
30000
Registration Number
NCT07068633
Locations
🇰🇷

Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

The Characteristics and Treatment Mechanism of Vascular Grafts in Elderly Patients With CAOD Through Single-cell Transcriptome Analysis

Recruiting
Conditions
Coronary Artery Occlusive Disease (CAOD)
First Posted Date
2025-07-08
Last Posted Date
2025-07-08
Lead Sponsor
Yonsei University
Target Recruit Count
100
Registration Number
NCT07053254
Locations
🇰🇷

Division of Cardiovascular Surgery, Severance Cardiovascular Hospital , Yonsei University College of Medicine, Seoul, Korea, Republic of

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 265
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.